Interestingly, in vivo experiments revealed significantly smaller tumor volumes and longer survival times after the individual knockout of either HIF1α or HIF2α compared to those in the control group, which may be due to microenvironmental differences between in vivo and in vitro studies. The gene discussed is HIF1A; the disease is neoplasm.